179 related articles for article (PubMed ID: 8188609)
1. gyrB mutations in coumermycin A1-resistant Borrelia burgdorferi.
Samuels DS; Marconi RT; Huang WM; Garon CF
J Bacteriol; 1994 May; 176(10):3072-5. PubMed ID: 8188609
[TBL] [Abstract][Full Text] [Related]
2. Genetic transformation of the Lyme disease agent Borrelia burgdorferi with coumarin-resistant gyrB.
Samuels DS; Mach KE; Garon CF
J Bacteriol; 1994 Oct; 176(19):6045-9. PubMed ID: 7928965
[TBL] [Abstract][Full Text] [Related]
3. Mutations in Bartonella bacilliformis gyrB confer resistance to coumermycin A1.
Battisti JM; Smitherman LS; Samuels DS; Minnick MF
Antimicrob Agents Chemother; 1998 Nov; 42(11):2906-13. PubMed ID: 9797224
[TBL] [Abstract][Full Text] [Related]
4. Oligonucleotide-mediated genetic transformation of Borrelia burgdorferi.
Samuels DS; Garon CF
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():519-522. PubMed ID: 9043127
[TBL] [Abstract][Full Text] [Related]
5. Directed insertion of a selectable marker into a circular plasmid of Borrelia burgdorferi.
Rosa P; Samuels DS; Hogan D; Stevenson B; Casjens S; Tilly K
J Bacteriol; 1996 Oct; 178(20):5946-53. PubMed ID: 8830691
[TBL] [Abstract][Full Text] [Related]
6. Brachyspira (Serpulina) hyodysenteriae gyrB mutants and interstrain transfer of coumermycin A(1) resistance.
Stanton TB; Matson EG; Humphrey SB
Appl Environ Microbiol; 2001 May; 67(5):2037-43. PubMed ID: 11319078
[TBL] [Abstract][Full Text] [Related]
7. An unusual mechanism for resistance to the antibiotic coumermycin A1.
del Castillo I; Vizán JL; Rodríguez-Sáinz MC; Moreno F
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8860-4. PubMed ID: 1656457
[TBL] [Abstract][Full Text] [Related]
8. Efficient targeted mutagenesis in Borrelia burgdorferi.
Bono JL; Elias AF; Kupko JJ; Stevenson B; Tilly K; Rosa P
J Bacteriol; 2000 May; 182(9):2445-52. PubMed ID: 10762244
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of the gyrB region of the oral spirochete, Treponema denticola.
Greene SR; Stamm LV
Gene; 2000 Aug; 253(2):259-69. PubMed ID: 10940564
[TBL] [Abstract][Full Text] [Related]
10. Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.
Fournier B; Hooper DC
Antimicrob Agents Chemother; 1998 Jan; 42(1):121-8. PubMed ID: 9449271
[TBL] [Abstract][Full Text] [Related]
11. GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.
Stieger M; Angehrn P; Wohlgensinger B; Gmünder H
Antimicrob Agents Chemother; 1996 Apr; 40(4):1060-2. PubMed ID: 8849232
[TBL] [Abstract][Full Text] [Related]
12. gyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase.
Contreras A; Maxwell A
Mol Microbiol; 1992 Jun; 6(12):1617-24. PubMed ID: 1323022
[TBL] [Abstract][Full Text] [Related]
13. Coumermycin A1 inhibits growth and induces relaxation of supercoiled plasmids in Borrelia burgdorferi, the Lyme disease agent.
Samuels DS; Garon CF
Antimicrob Agents Chemother; 1993 Jan; 37(1):46-50. PubMed ID: 8381639
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the Borrelia burgdorferi gac gene, encoding the naturally synthesized GyrA C-terminal domain.
Knight SW; Kimmel BJ; Eggers CH; Samuels DS
J Bacteriol; 2000 Apr; 182(7):2048-51. PubMed ID: 10715016
[TBL] [Abstract][Full Text] [Related]
15. Resistance genes of aminocoumarin producers: two type II topoisomerase genes confer resistance against coumermycin A1 and clorobiocin.
Schmutz E; Mühlenweg A; Li SM; Heide L
Antimicrob Agents Chemother; 2003 Mar; 47(3):869-77. PubMed ID: 12604514
[TBL] [Abstract][Full Text] [Related]
16. DNA gyrase activities from Rhodobacter capsulatus: analysis of target(s) of coumarins and cloning of the gyrB locus.
Kranz RG; Beckman DL; Foster-Hartnett D
FEMS Microbiol Lett; 1992 May; 72(1):25-32. PubMed ID: 1319375
[TBL] [Abstract][Full Text] [Related]
17. New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.
Aleixandre V; Urios A; Herrera G; Blanco M
Mol Gen Genet; 1989 Oct; 219(1-2):306-12. PubMed ID: 2559316
[TBL] [Abstract][Full Text] [Related]
18. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
Hooper DC; Wolfson JS; McHugh GL; Winters MB; Swartz MN
Antimicrob Agents Chemother; 1982 Oct; 22(4):662-71. PubMed ID: 6295263
[TBL] [Abstract][Full Text] [Related]
19. Construction and characterization of mutations at codon 751 of the Escherichia coli gyrB gene that confer resistance to the antimicrobial peptide microcin B17 and alter the activity of DNA gyrase.
del Castillo FJ; del Castillo I; Moreno F
J Bacteriol; 2001 Mar; 183(6):2137-40. PubMed ID: 11222617
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of mutations in both gyrB and parE genes is associated with high-level resistance to novobiocin in Staphylococcus aureus.
Fujimoto-Nakamura M; Ito H; Oyamada Y; Nishino T; Yamagishi J
Antimicrob Agents Chemother; 2005 Sep; 49(9):3810-5. PubMed ID: 16127057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
